Autonomix Medical, Inc.

Autonomix Medical, Inc.

NNASDAQ:AMIX
1.10
USD
-0.27
(-19.71%)
-17.07EPS
7.51MMarket Cap
Mar 03Next Earn

Total Valuation

USD

As of September 30, 2026, Autonomix Medical, Inc. carries a market capitalization of 7.51M, placing it among publicly traded companies globally. Its enterprise value stands at -185,437.46, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap7.51M
Enterprise Value-185,437.46

Important Dates

Autonomix Medical, Inc.'s next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of September 30, 2026, Autonomix Medical, Inc. has 1.96M shares outstanding.

Shares Outstanding1.96M

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio1.08
P/TBV Ratio1.08
P/FCF Ratio-0.22
P/OCF Ratio-0.22

Financial Position

As of September 30, 2026, Autonomix Medical, Inc. maintains a current ratio of 6.52, meaning it holds 6.5x the short-term assets needed to cover near-term liabilities.

Current Ratio6.52
Quick Ratio6.13

Financial Efficiency

Over the twelve months ended September 30, 2026, Autonomix Medical, Inc. posted a negative return on equity (ROE) of -176.02, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -146.10, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 11.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-176.02
Return on Assets (ROA)-146.10
Employee Count11.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Autonomix Medical, Inc.'s stock has declined approximately 92.79% over the past 52 weeks. The 50-day moving average sits at 2.99, while the 200-day moving average is 6.36.

52-Week Price Change-92.79%
50-Day Moving Average2.99
200-Day Moving Average6.36

Income Statement

USD

Over the twelve months ended September 30, 2026, Autonomix Medical, Inc. generated - - in revenue and converted that into -11.78M in net income, yielding earnings per share of -17.07. EBITDA reached -12.01M, while operating income came in at -12.03M.

Operating Income-12.03M
Pretax Income-11.78M
Net Income-11.78M
EBITDA-12.01M
EBIT-12.03M
Earnings Per Share (EPS)-17.07

Balance Sheet

USD

These figures are as of September 30, 2026. Total book value stands at 6.94M, with working capital of 6.92M providing operational flexibility.

Cash & Cash Equivalents7.69M
Net Debt-7.69M
Equity (Book Value)6.94M
Book Value Per Share3.54
Working Capital6.92M

Cash Flow

USD

Autonomix Medical, Inc. produced -12.02M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -10,000.00 in capital expenditures, free cash flow totaled -12.03M - equivalent to -17.43 per share.

Operating Cash Flow-12.02M
Capital Expenditures-10,000.00
Free Cash Flow-12.03M
FCF Per Share-17.43

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -455.01: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -163.19, meaning Autonomix Medical, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-163.19
FCF Yield-455.01

Stock Splits

Autonomix Medical, Inc.'s most recent stock split took place on June 24, 2026 with a 21:1 split ratio.

Last Split Date6/24/2026
Split Ratio21:1

Scores

As of September 30, 2026, Autonomix Medical, Inc. has an Altman Z-Score of -12.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-12.70